Biopsy for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Mar 2026: Trial started, NCT07477457
  2. 17 Mar 2026: Trial registered, NCT07477457

The trials

NCT07477457: A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

State
Under way
Phase
Phase 2
People
45 planned
Started
11 Mar 2026
Primary completion
Mar 2028
Arms
Newly Diagnosed Osteosarcoma
Results
None posted
  1. 11 Mar 2026: Trial started
  2. 17 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Surgery or procedure.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.